Company Profile of Linyi Aoguang Yuanda Biotechnology Co., Ltd.

Company Profile: Linyi Aoguang Yuanda Biotechnology Co., Ltd. was established in 2020, located in Linyi Economic Development Zone, Shandong Province, covering an area of 40 mu, with 50 employees, 10 technicians and 5 senior technicians. With a total investment of 35 million yuan, the company has built two modern standard production lines with an annual output of 200 tons of chenodeoxycholic acid, 100 tons of ursodeoxycholic acid and 200 tons of bile paste. The main products are chenodeoxycholic acid (CDCA), ursodeoxycholic acid (UDCA), cholic acid and bile paste. Products can be produced according to customer needs. The company's product sales network covers China, Korean and Indian markets, and its product quality and market share are in the leading position in China. Product quality is the lifeblood of the company's development. With strict production management system and product quality inspection system, the company samples and tests all related products in the whole process to ensure the quality of each batch of products is reliable. "Sincere cooperation and win-win together" is the development concept of our company, and we sincerely look forward to "sincere cooperation and win-win together" with you! Product Description: chenodeoxycholic acid (CDCA) is one of the most widely used drugs for treating gallstones in the world at present, and it is also the main raw material for synthesizing ursodeoxycholic acid (UDCA) and other steroid compounds, which has a huge market. Ursodeoxycholic acid (UDCA) is a hydrophilic cholic acid with white powder. Medically, it is used to increase bile acid secretion, change bile components, reduce cholesterol and cholesterol fat in bile, and help cholesterol in gallstones gradually dissolve.